Petunidin, a B-ring 5′-O-Methylated Derivative of Delphinidin, Stimulates Osteoblastogenesis and Reduces sRANKL-Induced Bone Loss

Several lines of evidence suggest that oxidative stress is one of the key pathogenic mechanisms of osteoporosis. We aimed to elucidate the bone protective effects of petunidin, one of the most common anthocyanidins, considering its potent antioxidative activity. Petunidin (>5 μg/mL) significantly...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 20; no. 11; p. 2795
Main Authors Nagaoka, Masahiro, Maeda, Toyonobu, Moriwaki, Sawako, Nomura, Atsushi, Kato, Yasumasa, Niida, Shumpei, Kruger, Marlena C., Suzuki, Keiko
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 07.06.2019
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Several lines of evidence suggest that oxidative stress is one of the key pathogenic mechanisms of osteoporosis. We aimed to elucidate the bone protective effects of petunidin, one of the most common anthocyanidins, considering its potent antioxidative activity. Petunidin (>5 μg/mL) significantly inhibited osteoclastogenesis and downregulated c-fos, Nfatc1, Mmp9, Ctsk, and Dc-stamp mRNA expression in RAW264.7 cells. Conversely, petunidin (>16 μg/mL) stimulated mineralized matrix formation and gene expression of Bmp2 and Ocn, whereas it suppressed Mmp13, Mmp2, and Mmp9 mRNA expression and proteolytic activities of MMP13 and MMP9 in MC3T3-E1 cells. Micro-CT and bone histomorphometry analyses of sRANKL-induced osteopenic C57BL/6J mice showed that daily oral administration of petunidin (7.5 mg/kg/day) increased bone volume to tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), the ratio of osteoid volume to tissue volume (OV/TV), osteoid thickness (O.Th), the ratio of osteoid surface to bone surface (OS/BS), the ratio of osteoblast surface to bone surface (Ob.S/BS), and the number of osteoblast per unit of bone surface (N.Ob/BS), and decreased trabecular separation (Tb.Sp), the ratio of eroded surface to bone surface (ES/BS), the ratio of osteoclast surface to bone surface (Oc.S/BS), and number of osteoclast per unit of bone surface (N.Oc/BS), compared to untreated mice. Furthermore, histological sections of the femurs showed that oral administration of petunidin to sRANKL-induced osteopenic mice increased the size of osteoblasts located along the bone surface and the volume of osteoid was consistent with the in vitro osteoblast differentiation and MMP inhibition. These results suggest that petunidin is a promising natural agent to improve sRANKL-induced osteopenia in mice through increased osteoid formation, reflecting accelerated osteoblastogenesis, concomitant with suppressed bone resorption.
AbstractList Several lines of evidence suggest that oxidative stress is one of the key pathogenic mechanisms of osteoporosis. We aimed to elucidate the bone protective effects of petunidin, one of the most common anthocyanidins, considering its potent antioxidative activity. Petunidin (>5 μg/mL) significantly inhibited osteoclastogenesis and downregulated , , , , and mRNA expression in RAW264.7 cells. Conversely, petunidin (>16 μg/mL) stimulated mineralized matrix formation and gene expression of and , whereas it suppressed , , and mRNA expression and proteolytic activities of and in MC3T3-E1 cells. Micro-CT and bone histomorphometry analyses of sRANKL-induced osteopenic C57BL/6J mice showed that daily oral administration of petunidin (7.5 mg/kg/day) increased bone volume to tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), the ratio of osteoid volume to tissue volume (OV/TV), osteoid thickness (O.Th), the ratio of osteoid surface to bone surface (OS/BS), the ratio of osteoblast surface to bone surface (Ob.S/BS), and the number of osteoblast per unit of bone surface (N.Ob/BS), and decreased trabecular separation (Tb.Sp), the ratio of eroded surface to bone surface (ES/BS), the ratio of osteoclast surface to bone surface (Oc.S/BS), and number of osteoclast per unit of bone surface (N.Oc/BS), compared to untreated mice. Furthermore, histological sections of the femurs showed that oral administration of petunidin to sRANKL-induced osteopenic mice increased the size of osteoblasts located along the bone surface and the volume of osteoid was consistent with the in vitro osteoblast differentiation and MMP inhibition. These results suggest that petunidin is a promising natural agent to improve sRANKL-induced osteopenia in mice through increased osteoid formation, reflecting accelerated osteoblastogenesis, concomitant with suppressed bone resorption.
Several lines of evidence suggest that oxidative stress is one of the key pathogenic mechanisms of osteoporosis. We aimed to elucidate the bone protective effects of petunidin, one of the most common anthocyanidins, considering its potent antioxidative activity. Petunidin (>5 μg/mL) significantly inhibited osteoclastogenesis and downregulated c-fos, Nfatc1, Mmp9, Ctsk, and Dc-stamp mRNA expression in RAW264.7 cells. Conversely, petunidin (>16 μg/mL) stimulated mineralized matrix formation and gene expression of Bmp2 and Ocn, whereas it suppressed Mmp13, Mmp2, and Mmp9 mRNA expression and proteolytic activities of MMP13 and MMP9 in MC3T3-E1 cells. Micro-CT and bone histomorphometry analyses of sRANKL-induced osteopenic C57BL/6J mice showed that daily oral administration of petunidin (7.5 mg/kg/day) increased bone volume to tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), the ratio of osteoid volume to tissue volume (OV/TV), osteoid thickness (O.Th), the ratio of osteoid surface to bone surface (OS/BS), the ratio of osteoblast surface to bone surface (Ob.S/BS), and the number of osteoblast per unit of bone surface (N.Ob/BS), and decreased trabecular separation (Tb.Sp), the ratio of eroded surface to bone surface (ES/BS), the ratio of osteoclast surface to bone surface (Oc.S/BS), and number of osteoclast per unit of bone surface (N.Oc/BS), compared to untreated mice. Furthermore, histological sections of the femurs showed that oral administration of petunidin to sRANKL-induced osteopenic mice increased the size of osteoblasts located along the bone surface and the volume of osteoid was consistent with the in vitro osteoblast differentiation and MMP inhibition. These results suggest that petunidin is a promising natural agent to improve sRANKL-induced osteopenia in mice through increased osteoid formation, reflecting accelerated osteoblastogenesis, concomitant with suppressed bone resorption.
Several lines of evidence suggest that oxidative stress is one of the key pathogenic mechanisms of osteoporosis. We aimed to elucidate the bone protective effects of petunidin, one of the most common anthocyanidins, considering its potent antioxidative activity. Petunidin (>5 μg/mL) significantly inhibited osteoclastogenesis and downregulated c-fos, Nfatc1, Mmp9, Ctsk, and Dc-stamp mRNA expression in RAW264.7 cells. Conversely, petunidin (>16 μg/mL) stimulated mineralized matrix formation and gene expression of Bmp2 and Ocn, whereas it suppressed Mmp13, Mmp2, and Mmp9 mRNA expression and proteolytic activities of MMP13 and MMP9 in MC3T3-E1 cells. Micro-CT and bone histomorphometry analyses of sRANKL-induced osteopenic C57BL/6J mice showed that daily oral administration of petunidin (7.5 mg/kg/day) increased bone volume to tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), the ratio of osteoid volume to tissue volume (OV/TV), osteoid thickness (O.Th), the ratio of osteoid surface to bone surface (OS/BS), the ratio of osteoblast surface to bone surface (Ob.S/BS), and the number of osteoblast per unit of bone surface (N.Ob/BS), and decreased trabecular separation (Tb.Sp), the ratio of eroded surface to bone surface (ES/BS), the ratio of osteoclast surface to bone surface (Oc.S/BS), and number of osteoclast per unit of bone surface (N.Oc/BS), compared to untreated mice. Furthermore, histological sections of the femurs showed that oral administration of petunidin to sRANKL-induced osteopenic mice increased the size of osteoblasts located along the bone surface and the volume of osteoid was consistent with the in vitro osteoblast differentiation and MMP inhibition. These results suggest that petunidin is a promising natural agent to improve sRANKL-induced osteopenia in mice through increased osteoid formation, reflecting accelerated osteoblastogenesis, concomitant with suppressed bone resorption.Several lines of evidence suggest that oxidative stress is one of the key pathogenic mechanisms of osteoporosis. We aimed to elucidate the bone protective effects of petunidin, one of the most common anthocyanidins, considering its potent antioxidative activity. Petunidin (>5 μg/mL) significantly inhibited osteoclastogenesis and downregulated c-fos, Nfatc1, Mmp9, Ctsk, and Dc-stamp mRNA expression in RAW264.7 cells. Conversely, petunidin (>16 μg/mL) stimulated mineralized matrix formation and gene expression of Bmp2 and Ocn, whereas it suppressed Mmp13, Mmp2, and Mmp9 mRNA expression and proteolytic activities of MMP13 and MMP9 in MC3T3-E1 cells. Micro-CT and bone histomorphometry analyses of sRANKL-induced osteopenic C57BL/6J mice showed that daily oral administration of petunidin (7.5 mg/kg/day) increased bone volume to tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), the ratio of osteoid volume to tissue volume (OV/TV), osteoid thickness (O.Th), the ratio of osteoid surface to bone surface (OS/BS), the ratio of osteoblast surface to bone surface (Ob.S/BS), and the number of osteoblast per unit of bone surface (N.Ob/BS), and decreased trabecular separation (Tb.Sp), the ratio of eroded surface to bone surface (ES/BS), the ratio of osteoclast surface to bone surface (Oc.S/BS), and number of osteoclast per unit of bone surface (N.Oc/BS), compared to untreated mice. Furthermore, histological sections of the femurs showed that oral administration of petunidin to sRANKL-induced osteopenic mice increased the size of osteoblasts located along the bone surface and the volume of osteoid was consistent with the in vitro osteoblast differentiation and MMP inhibition. These results suggest that petunidin is a promising natural agent to improve sRANKL-induced osteopenia in mice through increased osteoid formation, reflecting accelerated osteoblastogenesis, concomitant with suppressed bone resorption.
Several lines of evidence suggest that oxidative stress is one of the key pathogenic mechanisms of osteoporosis. We aimed to elucidate the bone protective effects of petunidin, one of the most common anthocyanidins, considering its potent antioxidative activity. Petunidin (>5 μg/mL) significantly inhibited osteoclastogenesis and downregulated c-fos , Nfatc1 , Mmp9 , Ctsk , and Dc-stamp mRNA expression in RAW264.7 cells. Conversely, petunidin (>16 μg/mL) stimulated mineralized matrix formation and gene expression of Bmp2 and Ocn , whereas it suppressed Mmp13 , Mmp2 , and Mmp9 mRNA expression and proteolytic activities of MMP13 and MMP9 in MC3T3-E1 cells. Micro-CT and bone histomorphometry analyses of sRANKL-induced osteopenic C57BL/6J mice showed that daily oral administration of petunidin (7.5 mg/kg/day) increased bone volume to tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), the ratio of osteoid volume to tissue volume (OV/TV), osteoid thickness (O.Th), the ratio of osteoid surface to bone surface (OS/BS), the ratio of osteoblast surface to bone surface (Ob.S/BS), and the number of osteoblast per unit of bone surface (N.Ob/BS), and decreased trabecular separation (Tb.Sp), the ratio of eroded surface to bone surface (ES/BS), the ratio of osteoclast surface to bone surface (Oc.S/BS), and number of osteoclast per unit of bone surface (N.Oc/BS), compared to untreated mice. Furthermore, histological sections of the femurs showed that oral administration of petunidin to sRANKL-induced osteopenic mice increased the size of osteoblasts located along the bone surface and the volume of osteoid was consistent with the in vitro osteoblast differentiation and MMP inhibition. These results suggest that petunidin is a promising natural agent to improve sRANKL-induced osteopenia in mice through increased osteoid formation, reflecting accelerated osteoblastogenesis, concomitant with suppressed bone resorption.
Author Maeda, Toyonobu
Nagaoka, Masahiro
Nomura, Atsushi
Kruger, Marlena C.
Niida, Shumpei
Suzuki, Keiko
Kato, Yasumasa
Moriwaki, Sawako
AuthorAffiliation 4 AKITAYA HONTEN Co., Ltd., Gifu 500-8471, Japan; a-nomura@akitayahonten.co.jp
5 School of Health Sciences, College of Health, Massey University, Palmerston North 4442, New Zealand; M.C.Kruger@massey.ac.nz
1 Department of Pharmacology, School of Dentistry, Ohu University, Fukushima 963-8611, Japan; m-nagaoka@den.ohu-u.ac.jp
6 Department of Pharmacology, School of Dentistry, Showa University, Tokyo 142-8555, Japan
2 Department of Oral Function and Molecular Biology, School of Dentistry, Ohu University, Fukushima 963-8611, Japan; t-maeda@den.ohu-u.ac.jp (T.M.); yasumasa-kato@umin.ac.jp (Y.K.)
3 Medical Genome Center, National Center for Geriatrics and Gerontology (NCGG), Aichi 474-8511, Japan; cyawa@ncvc.go.jp (S.M.); sniida@ncgg.go.jp (S.N.)
AuthorAffiliation_xml – name: 4 AKITAYA HONTEN Co., Ltd., Gifu 500-8471, Japan; a-nomura@akitayahonten.co.jp
– name: 1 Department of Pharmacology, School of Dentistry, Ohu University, Fukushima 963-8611, Japan; m-nagaoka@den.ohu-u.ac.jp
– name: 3 Medical Genome Center, National Center for Geriatrics and Gerontology (NCGG), Aichi 474-8511, Japan; cyawa@ncvc.go.jp (S.M.); sniida@ncgg.go.jp (S.N.)
– name: 2 Department of Oral Function and Molecular Biology, School of Dentistry, Ohu University, Fukushima 963-8611, Japan; t-maeda@den.ohu-u.ac.jp (T.M.); yasumasa-kato@umin.ac.jp (Y.K.)
– name: 6 Department of Pharmacology, School of Dentistry, Showa University, Tokyo 142-8555, Japan
– name: 5 School of Health Sciences, College of Health, Massey University, Palmerston North 4442, New Zealand; M.C.Kruger@massey.ac.nz
Author_xml – sequence: 1
  givenname: Masahiro
  surname: Nagaoka
  fullname: Nagaoka, Masahiro
– sequence: 2
  givenname: Toyonobu
  surname: Maeda
  fullname: Maeda, Toyonobu
– sequence: 3
  givenname: Sawako
  surname: Moriwaki
  fullname: Moriwaki, Sawako
– sequence: 4
  givenname: Atsushi
  surname: Nomura
  fullname: Nomura, Atsushi
– sequence: 5
  givenname: Yasumasa
  orcidid: 0000-0003-0192-9324
  surname: Kato
  fullname: Kato, Yasumasa
– sequence: 6
  givenname: Shumpei
  surname: Niida
  fullname: Niida, Shumpei
– sequence: 7
  givenname: Marlena C.
  orcidid: 0000-0002-8646-9672
  surname: Kruger
  fullname: Kruger, Marlena C.
– sequence: 8
  givenname: Keiko
  surname: Suzuki
  fullname: Suzuki, Keiko
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31181661$$D View this record in MEDLINE/PubMed
BookMark eNptksluFDEQhi0URBa4cUaWuHBIg5de7AtSEraIgUEBzpa7XT3jUbc9sd0j5YbEG_FIPAkeZYKGiJNdqq9-_bUcowPnHSD0lJKXnEvyyq7GyAilrJHVA3RES8YKQurmYO9_iI5jXBHCOKvkI3TIKRW0rukR-vkF0uSsse4Ua3xeBOsWuPr941cxLz5BWt4MOoHBbyDYjU52A9j3ORrWS7ur-prsOG2piOcxgW8HHZNfgINoI9bO4CswU5fT8ers88dZcem2ocHnuQ888zE-Rg97PUR4sntP0Pd3b79dfChm8_eXF2ezoiuJSIU0NWl5KY3pe9mYrq85NKChF1xqYRpeV7UgLZSN4LzvelkK2YDhrcjZtqX8BL2-1V1P7QimA5eCHtQ62FGHG-W1Vf9mnF2qhd-ous5DZCILvNgJBH89QUxqtLGDYdAO_BQVy9PlFWtKltHn99CVn4LL7WWqlLLkTMhMPdt39NfK3X4ywG6BLuRBBehVZ1Peg98atIOiRG2PQO0fQS46vVd0p_tf_A8_IrXf
CitedBy_id crossref_primary_10_3390_antiox13091143
crossref_primary_10_1016_j_plaphy_2024_109268
crossref_primary_10_3390_ijms21207623
crossref_primary_10_1016_j_intimp_2024_113531
crossref_primary_10_3390_cells12222666
crossref_primary_10_3390_ijms25115873
crossref_primary_10_1016_j_foodchem_2021_130425
crossref_primary_10_1016_j_ejmech_2024_116335
crossref_primary_10_1080_10826068_2021_1881906
crossref_primary_10_1016_j_jaim_2023_100823
crossref_primary_10_1002_smll_202006287
crossref_primary_10_3390_ijms20205196
crossref_primary_10_3390_ijms252212091
crossref_primary_10_1016_j_jfca_2022_104491
crossref_primary_10_3389_fendo_2023_1168687
crossref_primary_10_3389_fphar_2021_773660
crossref_primary_10_1016_j_cellimm_2024_104858
crossref_primary_10_3389_fendo_2021_779638
crossref_primary_10_3390_molecules28145364
crossref_primary_10_3390_ijms251910437
crossref_primary_10_1016_j_tem_2020_11_007
crossref_primary_10_3390_nu15040919
crossref_primary_10_1039_D2RA08284E
crossref_primary_10_3390_ijms21030714
crossref_primary_10_3389_fgene_2021_680115
crossref_primary_10_3390_molecules26030537
crossref_primary_10_3390_ijms21207570
Cites_doi 10.1016/S0031-9422(03)00438-2
10.1074/jbc.M411313200
10.1126/science.7939685
10.1056/NEJM198803313181305
10.1016/j.fct.2017.11.032
10.1016/j.lfs.2004.08.025
10.1138/20100467
10.1186/ar401
10.3390/molecules23092327
10.1172/JCI200318859
10.1016/j.jnutbio.2007.09.004
10.1111/j.1600-0625.2008.00829.x
10.1111/bph.13627
10.1002/jbmr.137
10.1016/j.bonr.2015.03.003
10.1038/nm.1954
10.3390/nu8010032
10.1093/gerona/gls163
10.1359/jbmr.090217
10.1016/j.jnutbio.2009.11.002
10.1371/journal.pone.0097177
10.1021/jf405356b
10.1210/er.2002-0023
10.1007/s00774-009-0088-0
10.1002/jbmr.1649
10.4103/0976-0105.177703
10.1146/annurev-food-041715-033346
10.1016/j.cccn.2005.04.014
10.1210/jc.2002-021496
10.1007/s11914-012-0119-y
10.1002/mnfr.200700092
10.1016/j.molmed.2005.11.007
10.1093/jn/133.6.1892
10.1016/j.canlet.2005.04.033
10.3390/nu9101089
10.1016/S0006-291X(05)80311-0
10.3945/an.115.009233
10.1210/edrv-14-4-424
10.1359/jbmr.070121
10.1016/j.bbrc.2003.12.073
10.1016/S1534-5807(02)00369-6
10.1359/jbmr.091017
10.1002/jbmr.141
10.1016/j.bbamcr.2009.07.004
10.3390/antiox3010144
10.1002/jbmr.1805
ContentType Journal Article
Copyright 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2019 by the authors. 2019
Copyright_xml – notice: 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2019 by the authors. 2019
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.3390/ijms20112795
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed
CrossRef
MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Dentistry
EISSN 1422-0067
ExternalDocumentID PMC6600628
31181661
10_3390_ijms20112795
Genre Journal Article
GeographicLocations China
Japan
GeographicLocations_xml – name: China
– name: Japan
GroupedDBID ---
29J
2WC
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESX
F5P
FRP
FYUFA
GNUQQ
GUQSH
GX1
HH5
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK8
M1P
M2O
M48
MODMG
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RPM
TR2
TUS
UKHRP
~8M
NPM
3V.
7XB
8FK
K9.
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c408t-9d60b349ddff97dcf63e7eaef839a8d7365680be47833fcf94897ed3b8a8dbb13
IEDL.DBID M48
ISSN 1422-0067
1661-6596
IngestDate Thu Aug 21 18:42:59 EDT 2025
Mon Jul 21 10:51:03 EDT 2025
Fri Jul 25 20:28:01 EDT 2025
Thu Apr 03 07:02:53 EDT 2025
Thu Apr 24 22:58:26 EDT 2025
Tue Jul 01 01:45:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords petunidin
anthocyanin
osteoblast
osteoclast
osteoporosis
bone anabolism
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c408t-9d60b349ddff97dcf63e7eaef839a8d7365680be47833fcf94897ed3b8a8dbb13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
Present Affiliation: Biobank, National Cerebral and Cardiovascular Center (NCVC), Osaka 564-8565, Japan.
ORCID 0000-0002-8646-9672
0000-0003-0192-9324
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms20112795
PMID 31181661
PQID 2249943289
PQPubID 2032341
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6600628
proquest_miscellaneous_2259352742
proquest_journals_2249943289
pubmed_primary_31181661
crossref_citationtrail_10_3390_ijms20112795
crossref_primary_10_3390_ijms20112795
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20190607
PublicationDateYYYYMMDD 2019-06-07
PublicationDate_xml – month: 6
  year: 2019
  text: 20190607
  day: 7
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2019
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Muthusami (ref_3) 2005; 360
McGhie (ref_9) 2007; 51
Wada (ref_28) 2006; 12
Afaq (ref_35) 2009; 18
ref_14
Canalis (ref_33) 2003; 24
Almeida (ref_4) 2010; 25
Zhang (ref_45) 2005; 76
ref_18
Li (ref_24) 2007; 22
ref_17
Dempster (ref_31) 2013; 28
Raisz (ref_1) 1988; 318
Kato (ref_48) 2005; 280
Vincenti (ref_38) 2001; 4
Nair (ref_42) 2016; 7
Lin (ref_15) 2017; 174
Welch (ref_22) 2012; 27
Wallace (ref_41) 2015; 6
Ghosh (ref_16) 2007; 16
Stein (ref_34) 1993; 14
Folgueras (ref_29) 2010; 1803
Chiba (ref_10) 2003; 133
Kim (ref_12) 2011; 22
Chang (ref_23) 2009; 15
Bai (ref_25) 2004; 314
Maggio (ref_5) 2003; 88
Grigoriadis (ref_26) 1994; 266
ref_36
ref_37
Devareddy (ref_13) 2008; 19
Chen (ref_46) 2006; 235
Tomimori (ref_30) 2009; 24
Maeda (ref_49) 2015; 2
Kong (ref_19) 2003; 64
Lila (ref_21) 2016; 7
Tsuji (ref_11) 2009; 27
Hubert (ref_40) 2014; 3
Almeida (ref_6) 2010; 7
Chen (ref_39) 2010; 25
Skates (ref_32) 2018; 111
Lean (ref_2) 2003; 112
Bouxsein (ref_50) 2010; 25
ref_44
Khosla (ref_7) 2013; 68
ref_43
Takayanagi (ref_27) 2002; 3
Levis (ref_8) 2012; 10
Fang (ref_20) 2014; 62
Bax (ref_47) 1992; 183
References_xml – volume: 64
  start-page: 923
  year: 2003
  ident: ref_19
  article-title: Analysis and biological activities of anthocyanins
  publication-title: Phytochemistry
  doi: 10.1016/S0031-9422(03)00438-2
– volume: 280
  start-page: 10938
  year: 2005
  ident: ref_48
  article-title: Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M411313200
– volume: 266
  start-page: 443
  year: 1994
  ident: ref_26
  article-title: c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
  publication-title: Science
  doi: 10.1126/science.7939685
– volume: 318
  start-page: 818
  year: 1988
  ident: ref_1
  article-title: Local and systemic factors in the pathogenesis of osteoporosis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM198803313181305
– volume: 111
  start-page: 445
  year: 2018
  ident: ref_32
  article-title: Berries containing anthocyanins with enhanced methylation profiles are more effective at ameliorating high fat diet-induced metabolic damage
  publication-title: Food Chem. Toxicol.
  doi: 10.1016/j.fct.2017.11.032
– volume: 76
  start-page: 1465
  year: 2005
  ident: ref_45
  article-title: Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2004.08.025
– volume: 7
  start-page: 340
  year: 2010
  ident: ref_6
  article-title: Aging and oxidative stress: A new look at old bone
  publication-title: IBMS BoneKEy
  doi: 10.1138/20100467
– volume: 16
  start-page: 200
  year: 2007
  ident: ref_16
  article-title: Anthocyanins and anthocyanin-rich extracts: Role in diabetes and eye function
  publication-title: Asia Pac. J. Clin. Nutr.
– volume: 4
  start-page: 157
  year: 2001
  ident: ref_38
  article-title: Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: Integration of complex signaling pathways for the recruitment of gene-specific transcription factors
  publication-title: Arthritis Res.
  doi: 10.1186/ar401
– ident: ref_36
  doi: 10.3390/molecules23092327
– volume: 112
  start-page: 915
  year: 2003
  ident: ref_2
  article-title: A crucial role for thiol antioxidants in estrogen-deficiency bone loss
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI200318859
– volume: 19
  start-page: 694
  year: 2008
  ident: ref_13
  article-title: Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis
  publication-title: J. Nutr. Biochem.
  doi: 10.1016/j.jnutbio.2007.09.004
– volume: 18
  start-page: 553
  year: 2009
  ident: ref_35
  article-title: Protective effect of pomegranate-derived products on UVB-mediated damage in human reconstituted skin
  publication-title: Exp. Dermatol.
  doi: 10.1111/j.1600-0625.2008.00829.x
– volume: 174
  start-page: 1226
  year: 2017
  ident: ref_15
  article-title: Effects of anthocyanins on the prevention and treatment of cancer
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/bph.13627
– volume: 25
  start-page: 2399
  year: 2010
  ident: ref_39
  article-title: Dietary-induced serum phenolic acids promote bone growth via p38 MAPK/β-catenin canonical Wnt signaling
  publication-title: J. Bone Miner. Res.
  doi: 10.1002/jbmr.137
– volume: 2
  start-page: 36
  year: 2015
  ident: ref_49
  article-title: Mineral trioxide aggregate induces osteoblastogenesis via Atf6
  publication-title: Bone Rep.
  doi: 10.1016/j.bonr.2015.03.003
– volume: 15
  start-page: 682
  year: 2009
  ident: ref_23
  article-title: Inhibition of osteoblastic bone formation by nuclear factor-κB
  publication-title: Nat. Med.
  doi: 10.1038/nm.1954
– ident: ref_18
  doi: 10.3390/nu8010032
– volume: 68
  start-page: 1226
  year: 2013
  ident: ref_7
  article-title: Pathogenesis of age-related bone loss in humans
  publication-title: J. Gerontol. A Biol. Sci. Med. Sci.
  doi: 10.1093/gerona/gls163
– volume: 24
  start-page: 1194
  year: 2009
  ident: ref_30
  article-title: Evaluation of Pharmaceuticals With a Novel 50-Hour Animal Model of Bone Loss
  publication-title: J. Bone Miner. Res.
  doi: 10.1359/jbmr.090217
– volume: 22
  start-page: 8
  year: 2011
  ident: ref_12
  article-title: The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss
  publication-title: J. Nutr. Biochem.
  doi: 10.1016/j.jnutbio.2009.11.002
– ident: ref_14
  doi: 10.1371/journal.pone.0097177
– volume: 62
  start-page: 3904
  year: 2014
  ident: ref_20
  article-title: Some Anthocyanins Could Be Efficiently Absorbed across the Gastrointestinal Mucosa: Extensive Presystemic Metabolism Reduces Apparent Bioavailability
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/jf405356b
– volume: 24
  start-page: 218
  year: 2003
  ident: ref_33
  article-title: Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton
  publication-title: Endocr. Rev.
  doi: 10.1210/er.2002-0023
– volume: 27
  start-page: 673
  year: 2009
  ident: ref_11
  article-title: Dietary quercetin inhibits bone loss without effect on the uterus in ovariectomized mice
  publication-title: J. Bone Miner. Metab.
  doi: 10.1007/s00774-009-0088-0
– volume: 27
  start-page: 1872
  year: 2012
  ident: ref_22
  article-title: Habitual flavonoid intakes are positively associated with bone mineral density in women
  publication-title: J. Bone Miner. Res.
  doi: 10.1002/jbmr.1649
– volume: 7
  start-page: 27
  year: 2016
  ident: ref_42
  article-title: A simple practice guide for dose conversion between animals and human
  publication-title: J. Basic Clin. Pharm.
  doi: 10.4103/0976-0105.177703
– ident: ref_37
– volume: 7
  start-page: 375
  year: 2016
  ident: ref_21
  article-title: Unraveling Anthocyanin Bioavailability for Human Health
  publication-title: Annu. Rev. Food Sci. Technol.
  doi: 10.1146/annurev-food-041715-033346
– ident: ref_44
– volume: 360
  start-page: 81
  year: 2005
  ident: ref_3
  article-title: Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cccn.2005.04.014
– volume: 88
  start-page: 1523
  year: 2003
  ident: ref_5
  article-title: Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2002-021496
– volume: 10
  start-page: 296
  year: 2012
  ident: ref_8
  article-title: The role of diet in osteoporosis prevention and management
  publication-title: Curr. Osteoporos. Rep.
  doi: 10.1007/s11914-012-0119-y
– volume: 51
  start-page: 702
  year: 2007
  ident: ref_9
  article-title: The bioavailability and absorption of anthocyanins: Towards a better understanding
  publication-title: Mol. Nutr. Food Res.
  doi: 10.1002/mnfr.200700092
– volume: 12
  start-page: 17
  year: 2006
  ident: ref_28
  article-title: RANKL-RANK signaling in osteoclastogenesis and bone disease
  publication-title: Trends Mol. Med.
  doi: 10.1016/j.molmed.2005.11.007
– volume: 133
  start-page: 1892
  year: 2003
  ident: ref_10
  article-title: Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice
  publication-title: J. Nutr.
  doi: 10.1093/jn/133.6.1892
– volume: 235
  start-page: 248
  year: 2006
  ident: ref_46
  article-title: Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2005.04.033
– ident: ref_17
  doi: 10.3390/nu9101089
– volume: 183
  start-page: 1153
  year: 1992
  ident: ref_47
  article-title: Stimulation of osteoclastic bone resorption by hydrogen peroxide
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/S0006-291X(05)80311-0
– volume: 6
  start-page: 620
  year: 2015
  ident: ref_41
  article-title: Anthocyanins
  publication-title: Adv. Nutr.
  doi: 10.3945/an.115.009233
– volume: 14
  start-page: 424
  year: 1993
  ident: ref_34
  article-title: Molecular Mechanisms Mediating Proliferation/Differentiation Interrelationships During Progressive Development of the Osteoblast Phenotype
  publication-title: Endocr. Rev.
  doi: 10.1210/edrv-14-4-424
– volume: 22
  start-page: 646
  year: 2007
  ident: ref_24
  article-title: Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB
  publication-title: J. Bone Miner. Res.
  doi: 10.1359/jbmr.070121
– volume: 314
  start-page: 197
  year: 2004
  ident: ref_25
  article-title: Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2003.12.073
– volume: 3
  start-page: 889
  year: 2002
  ident: ref_27
  article-title: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
  publication-title: Dev. Cell
  doi: 10.1016/S1534-5807(02)00369-6
– ident: ref_43
– volume: 25
  start-page: 769
  year: 2010
  ident: ref_4
  article-title: Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA binding-independent actions of the ERα
  publication-title: J. Bone Miner. Res.
  doi: 10.1359/jbmr.091017
– volume: 25
  start-page: 1468
  year: 2010
  ident: ref_50
  article-title: Guidelines for assessment of bone microstructure in rodents using micro-computed tomography
  publication-title: J. Bone Miner. Res.
  doi: 10.1002/jbmr.141
– volume: 1803
  start-page: 3
  year: 2010
  ident: ref_29
  article-title: Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamcr.2009.07.004
– volume: 3
  start-page: 144
  year: 2014
  ident: ref_40
  article-title: Dietary Polyphenols, Berries, and Age-Related Bone Loss: A Review Based on Human, Animal, and Cell Studies
  publication-title: Antioxidants
  doi: 10.3390/antiox3010144
– volume: 28
  start-page: 2
  year: 2013
  ident: ref_31
  article-title: Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
  publication-title: J. Bone Miner. Res.
  doi: 10.1002/jbmr.1805
SSID ssj0023259
Score 2.3922205
Snippet Several lines of evidence suggest that oxidative stress is one of the key pathogenic mechanisms of osteoporosis. We aimed to elucidate the bone protective...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2795
SubjectTerms Antioxidants
Arthritis
Cancer
Dentistry
Flavonoids
Food
Fruits
Genes
Kinases
Medical research
Natural & organic foods
Nutrition
Osteoporosis
Oxidative stress
Polyphenols
Vegetables
SummonAdditionalLinks – databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMEFQXkFCjISnMBqEjt-nFAfLBX0gQqVeouS2KZB22QhWSRuSPyj_qT-ks4k2bAFwTGZSWJnxp4ZezwfIc-l0HA_0UyArWIQf0VMx4Iz7uLYWO-KzONB4b19uXMk3h0nx8OCWzOkVS7mxG6itnWBa-TrYGqMERzig9ezrwxRo3B3dYDQuEquRWBpMKVLT96OARePO7C0CGwQk4mRfeI7hzB_vfxy2qDtixUiSyybpL_8zD_TJZfsz-Q2uTU4jnSjl_QdcsVVq-R6DyX5Y5Xc2Ma0H0Ruu0t-fXDtvCrBKr2iGd1kuHRHk_OfZ-yA7TmQzBQcTEu3Qfm-d3W_ae3hajo7KYenPrblKeJ6uYYegBrUOfjYbf0Z58WyoVll6SGWfAVyc7ix_36XIQJIAe_crCtHd6GX98jR5M2nrR02gC2wQoS6ZcbKMOfCWOu9UbbwkjvlMufBg8q0VRwcPx3mTijNuS-8EdooZ3mugZrnEb9PVir4xkNCObBrxCELw1zIPMsg_Faxj1QoRAYBU0BeLv53WgyVyBEQY5pCRILSSZelE5AXI_esr8DxD761hejSYRw26W-tCcizkQwjCLdFssrVc-RJDLih0MiAPOglPX6I47lcUJ-AqEs6MDJgde7LlKo86ap0S9mdT330_2Y9JjehA6ZLPlNrZKX9NndPwM1p86edLl8A7o3-pw
  priority: 102
  providerName: ProQuest
Title Petunidin, a B-ring 5′-O-Methylated Derivative of Delphinidin, Stimulates Osteoblastogenesis and Reduces sRANKL-Induced Bone Loss
URI https://www.ncbi.nlm.nih.gov/pubmed/31181661
https://www.proquest.com/docview/2249943289
https://www.proquest.com/docview/2259352742
https://pubmed.ncbi.nlm.nih.gov/PMC6600628
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB71ISQuiDeBsjISnMCQjZ3YPiDUhS4VdLfVwkp7i_JwaNA2KU0W0RsS_4ifxC9hJpuNuhQkLlEST2LH43i-8WM-gMeB1Hjf11yireLof_W59qTgwnqeSTObRBltFB6Ng_2pfDfzZxuwYhttK7D6q2tHfFLTs_nzb1_OX-EP_5I8TnTZX-SfTyqyY54y_iZso01SxGUwkt18AsKGhjaNBjw4ddDLJfCXnl43TpcQ558LJy9YouF1uNZCSLa71PkN2LDFTbiyJJU8vwU_jmy9KHK0Sc9YxAacBu6Y_-v7T37IRxb1Mkd4mbI32PS-NlG_WZnh1fz0OG-f-lDnJ8TqZSt2iI2gjBFh1-Un6hXzikVFyiYU8BWTq8nu-P0BJ_6PBN85KAvLDvDLbsN0uPfx9T5vqRZ4Il1dc5MGbiykSdMsMypNskBYZSObIX6KdKoEwj7txlYqLUSWZEZqo2wqYo2pcdwXd2CrwDzuARMoromFzHVjGcRRhM638rK-cqWM0F1y4OmqjsOkjUNOdBjzEP0R0kh4USMOPOmkT5fxN_4ht7NSV7hqRCHCE2OkQJ_SgUddMv4_NCkSFbZckIxvEIRiIR24u9Rul5GgXbkIYBxQa3rvBCg293pKkR83MbqDoNmdev8_i_8AruKpadagqR3Yqs8W9iGinTruwaaaKTzq4dsebA_2xkeTHtkfv9c08d8pcwRb
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3JbtRAEC2FIBQuCMJmCNBI5ASteNztpQ8IJQzDhFmCQiLl5nhpE6OJPWAPKDck_ocDn8SXUOWNCQhuOdpdXut1V5VdVQ_giSM93G97XKKt4hh_9bhnScGFtiwVJzoKEioUnkyd4aF8c2QfrcD3thaG0irbNbFaqOM8om_kW2hqlJIC44MX84-cWKPo72pLoVHDYqTPvmDIVjzf7aN-Ny1r8Org5ZA3rAI8kqZXchU7ZiikiuMkUW4cJY7Qrg50gq5C4MWuQA_HM0MtXU-IJEqU9JSrYxF6OBqGPYHnvQSXpUBLTpXpg9ddgCesipythzaPO7Zy6kR7FDS30g-nBdlayyUmi2UT-Jdf-2d65pK9G1yHa42jyrZrZN2AFZ2tw5WauvJsHdb6lGZETHE34dtbXS6yFK3gMxawHU6fCpn98-sPvscnGpEwQ4c2Zn0E--eqzzjLE9yazU_S5qh3ZXpKPGK6YHsIuzxEn77M39M6nBYsyGK2Ty1mcbjY356OxpwYRyI8506eaTbGp7wFhxeihtuwmuE17gITKO4R75lphtIJgwDDfddKeq4pZYABmgFP2_ftR03ncyLgmPkYAZF2_GXtGLDZSc_rjh__kNtoVec3877wf6PUgMfdMM5Y-g0TZDpfkIyt0O3FmzTgTq3p7kKC6oARPga45zDQCVA38PMjWXpSdQV3nKoe9t7_b-sRrA0PJmN_vDsd3Yer-DCqSnxzN2C1_LTQD9DFKsOHFa4ZHF_0RPoF3Sg9UA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVDwuCMqjgQKLRE-wiuPd2N4DQg1p1JI0jQKVejN-7LZGqR2wA-oNiX_EkZ_DL2HGdkIKgluP9o53bc-3OzP27HwAzxzp4fmOxyXaKo7xV5t7thRcaNtWsdFRYGij8MHI2TuSb447x2vwY7EXhtIqF2tiuVDHWUTfyFtoapSSAuODlqnTIsa9_qvZR04MUvSndUGnUUFkoM-_YPiWv9zvoa63bbu_--71Hq8ZBngkLa_gKnasUEgVx8YoN46MI7SrA23QbQi82BXo7XhWqKXrCWEio6SnXB2L0MPWMGwL7PcKrLsUFTVgvbs7Gk-W4Z6wS6q2NlpA7nSUU6XdC6GsVvLhLCfLa7vEa7FqEP_ycv9M1lyxfv1bcLN2W9lOhbPbsKbTDbhaEVmeb8D1HiUdEW_cHfg21sU8TdAmvmAB63L6cMg6P79-54f8QCMupujexqyH0P9cVh1nmcGj6ew0qa96WyRnxCqmc3aIIMxC9PCL7IRW5SRnQRqzCRWcxeZ8sjMaDDnxj0TYZzdLNRviU96Fo0tRxD1opDjGJjCB4h6xoFlWKJ0wCDD4d23Tdi0pAwzXmvB88b79qK6DTnQcUx_jIdKOv6qdJmwvpWdV_Y9_yG0tVOfXq0Du_8ZsE54um3H-0k-ZINXZnGQ6Cp1gvMkm3K80vRxI0K5ghE8T3AsYWApQbfCLLWlyWtYId5xyd-yD_9_WE7iGk8gf7o8GD-EGPosqs-DcLWgUn-b6EfpbRfi4BjaD95c9l34Bm7xC4g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Petunidin%2C+a+B-ring+5%E2%80%B2-O-Methylated+Derivative+of+Delphinidin%2C+Stimulates+Osteoblastogenesis+and+Reduces+sRANKL-Induced+Bone+Loss&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Nagaoka%2C+Masahiro&rft.au=Maeda%2C+Toyonobu&rft.au=Moriwaki%2C+Sawako&rft.au=Nomura%2C+Atsushi&rft.date=2019-06-07&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=20&rft.issue=11&rft.spage=2795&rft_id=info:doi/10.3390%2Fijms20112795&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_ijms20112795
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon